Stay updated with breaking news from Eric Assaraf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The agency proposes to remove the once-per-lifetime limit on beta amyloid PET scans that restricted their use to clinical trials. The changes will permit Medicare beneficiaries to seek reimbursement for the tests. "Today's announcement about Medicare coverage of amyloid PET scans fulfills CMS' commitment to allow broader coverage of this diagnostic test," said CMS Administrator Chiquita Brooks-LaSure.
The US government Medicare program on Tuesday said it plans to cover Alzheimer's treatments including Biogen Inc's Aduhelm but will require patients to be enrolled in a clinical trial, potentially limiting access.
-The U.S. government Medicare program on Tuesday said it plans to cover Alzheimer's treatments including Biogen Inc's Aduhelm but will require patients to be enrolled in a clinical trial, limiting... -January 11, 2022 at 10:04 pm EST - MarketScreener
Wall Street has high hopes for the big biomedical research package dubbed “Cures 2.0,” which Congress is poised to take up in the new year.
Graphite Health’s arrival is the latest development stemming from a 2020 plan to free up digital records.